Heterozygous large deletions of Factor 8 gene in females identified by multiplex PCR-LC by El Maarri, O. et al.
ORIGINAL ARTICLE Women with bleeding disorders
Heterozygous large deletions of Factor 8 gene in females
identified by multiplex PCR-LC
A. PAVLOVA,* T. FO¨RSTER, D. DELEV,* J. SCHRO¨DER,* O. EL-MAARRI,* C. MU¨LLER-REIBLE
and J. OLDENBURG*
*Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn; and Institute for
Human Genetics, University of Wu¨rzburg, Biocenter, Am Hubland, Wu¨rzburg, Germany
Summary. Haemophilia A is the most common
X-linked recessive bleeding disorder. In 5% of
severely affected patients the mutations responsible
for the disease are large deletions encompassing from
one exon to the complete Factor 8 (F8) gene. Large
deletions in a male haemophilic patient are easily
detected by the absence of the corresponding PCR
product. However, in female carriers, identification
of the various heterozygous large deletions is difficult
representing a major limitation to accurate carrier
diagnosis. The deletion is masked by the presence of
the second allele that serves as template for the PCR
reaction. Quantitative PCR can differentiate between
the presence of one or two alleles. Here we report an
assay based on multiplex amplification of several
exons of the F8 gene of various length and
subsequent quantitative evaluation of the amplicons
by liquid chromatogphy (LC). Using this approach
we achieved an accurate classification of 16 female
carriers and eight non-carriers for deletions in the F8
gene in 19 investigated families. One mother and one
grandmother were classified as non-carriers, under-
lining the high de novo mutation rate of large
deletions in female germ cells. The large deletions
in three families were confirmed by fluorescent in situ
hybridization. In conclusion, the multiplex PCR-LC
technique represents a rapid, simple and reliable
method for detection of heterozygous large deletions
in female carriers.
Keywords: haemophilia A carriers, large deletions,
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Introduction
Haemophilia A (HA) is the most common, severe
bleeding disorder affecting one in 5000 male new-
borns. The X-linked disease is caused by a broad
spectrum of mutations in the Factor 8 (F8) gene
leading to an absent or dysfunctional protein. The F8
gene spans 186 kb on chromosome Xq28 and
consists of 26 exons. Large deletions are not
uncommon events in HA and occur in approximately
5% of patients with a severe form of the disease [1].
More than 100 unrelated patients with large dele-
tions, encompassing one or more exons of the F8
gene, have been reported in the international F8
mutation database [2]. Because of the X-linked
inheritance, female relatives of HA patients with
large deletions are at risk for being carriers. There-
fore, the availability of an accurate carrier test for the
various heterozygous large deletions and appropriate
genetic counselling are important for comprehensive
care in haemophilia.
Large deletions of F8 in males are readily detected
by the absence of a PCR product of the deleted
fragment. However, to identify large deletions of
complete exons on the background of a normal allele
– as it is the situation in a carrier – is challenging as
the presence of the non-deleted allele masks the
deletion in a standard PCR. Indirect gene analysis by
classical segregation investigation of polymorphisms
for tracing the F8 gene defects within a pedigree is
limited because it requires examination of several
family members, may be uninformative in approxi-
mately 25% of potential carriers and cannot identify
de novo large deletion that preferably originate in
female germ cells [3–5]. Historically, the method of
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choice for the detection of large deletions relied on
Southern blotting. However, this approach is labour
intensive, requires large amounts of DNA, has a low
throughput, and is not able to detect all large
deletions. Therefore, the use of Southern blotting is
limited in routine molecular diagnosis. Alternative
approaches for the identification of female carriers of
heterozygous large deletions are quantitative PCR
techniques [6–8].
In the present study, we applied a quantitative
multiplex PCR and liquid chromatography (LC)
method for the detection of large deletions in 24
females from 19 families in whom a large deletion
was identified in the index patient.
Materials and methods
Patients
Nineteen families with severe HA (FVIII activity
<1%) and an index patient exhibiting a large deletion
of one or more exons were included in the study.
Presence of an intron 22/intron 1 inversion mutation
was excluded. The large deletion in the index patient
was detected by repetitive amplification failure of a
single or several contiguous exons. A total of 24
possible carriers were analysed for the presence of a
large deletion. All patients and relatives gave
informed consent according to the Declaration of
Helsinki.
F8 gene analysis
DNA isolation High molecular genomic DNA was
isolated from peripheral whole blood by a common
salting out procedure [9]. DNA concentrations were
standardized to 100 ng lL)1.
Intron 22 and intron 1-inversion PCR The PCR for
detection of the intron 22 inversion was performed
as described by Liu et al. [10] with the following
slight modifications: PCR-amplification started with
100 ng of DNA and the amplified fragments were
separated on 0.8% agarose gel for 24 h. Intron 1
inversion was analysed by PCR as reported earlier
with a modified annealing temperature of 59C [11].
PCR for amplification of the F8 gene in haemophilia
patients All 26 exons and flanking regions of the F8
gene were amplified by touchdown PCR. The reac-
tion was performed using 100 ng of genomic DNA,
20 pmol of primer, 50 lm of each dNTP and 2.5 U
of AmpliTaq-Gold DNA polymerase (PE Applied
Biosystems, Foster City, CA, USA) in a total volume
of 50 lL. The primers were designed to anneal at
59C for all exons. The PCR programme was set to
initial denaturation at 94C for 5 min, followed by
38 cycles of amplification with 30 s of denaturation
at 94C, 30 s of annealing with temperature ramping
from 65 to 59C by 3C every two cycles, 30 s
elongation at 72C and 5 min final extension at
72C. The amplicons were checked on an ethidium
bromide stained 1.5% agarose gel.
Semi-quantitative multiplex PCR A semi-quantitative
multiplex PCR was performed for detection of
heterozygous F8 large deletions in female relatives.
The touchdown PCR was performed using the same
conditions as described above, differing only by
number of cycles, which were reduced to 25 cycles to
ensure that the amplification reaction remained
within the exponential phase. Less than 22 cycles
did not yield enough PCR product for good resolu-
tion on LC and more than 25 cycles were too close to
the plateau phase. In designing the multiplex reaction
three important criteria were taken into consider-
ation: (i) One or more exons in which a deletion was
expected were selected for amplification. (ii)
A human growth hormone (HGH) gene fragment
with length of 440 bp (corresponding to HGH exons
3 and 4) was coamplified as an internal PCR control.
(iii) Undeleted exon(s) were amplified as a second
internal control. (iv) The length of the fragments
differs in at least 30 bp to allow a clear separation by
LC. Due to its size, exon 14 was divided into eight
fragments (Table 1).
LC analysis Aliquots of 10 lL of the multiplex PCR
product were injected into a semi-automated high
throughput LC system (WAVE; Transgenomic Ltd,
Omaha, USA). Separation was performed on
DNAsep cartridge (Ion pair reverse phase C18
column – Transgenomic Ltd) at constant oven
temperature of 50C ensuring non-denaturing con-
ditions and UV detection at 260 nm. The mobile
phase was 0.1 m triethylammonium acetate (TEAA),
pH 7 (buffer A) and 0.1 m TEAA and 25% acetoni-
tril (buffer B). The PCR product was eluted at a flow
rate of 0.9 mL min)1 with a gradient of 40–72% for
buffer B. navigator 1.5.3. Software (Transgenomic)
was used for data analysis. The chromatograms of
investigated patient samples were normalized
according to the internal HGH peak and superim-
posed on those of a normal control. The peak height
of each exon of the normal control and the investi-
gated sample were compared and a ratio for each
peak was calculated (peak height of test sample/peak
height of control). The yield of each amplicon in
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Table 1. Amplification primer sequences for Factor 8 and HGH genes.
Name Primer sequences (5¢ to 3¢) Length of PCR products (bp)
F8-Exon 1F ccctcctgggagctaaagat 293
F8-Exon 1R caccttcctccaagcagact
F8-Exon 2F ttcaaatttgcctccttgct 338
F8-Exon 2R tttggcagctgcacttttta
F8-Exon 3F gcttctccactgtgaccttga 250
F8-Exon 3R tgacaggacaataggagggtattt
F8-Exon 4F acatgtttctttgagtgtacagtgg 373
F8-Exon 4R caggtgaaggaacacaaatgc
F8-Exon 5F tcctcctagtgacaatttcctaca 193
F8-Exon 5R gtagcagaggatttctttcagga
F8-Exon 6F taaggtgtgagcacactggg 314
F8-Exon 6R tatcctctgagatgccgagc
F8-Exon 7F tgtcctagcaagtgttttccatt 400
F8-Exon 7R aatgtccccttcagcaacac
F8-Exon 8F cccatatagcctgcagaaacat 473
F8-Exon 8R tggcttcaggatttgttggt
F8-Exon 9F agagttggatttgagcctacctag 296
F8-Exon 9R cagactttttcttcttacctgacctt
F8-Exon 10F ctagcctcaaattactataatg 347
F8-Exon 10R actttagactggagcttgag
F8-Exon 11F gagacccttgcaacaacaac 364
F8-Exon 11R tttcttcaggttataaggggaca
F8-Exon 12F tgctagctcctacctgacaaca 298
F8-Exon 12R cattcattatctggacatcactttg
F8-Exon 13F atcatgacaatcacaatccaaaa 366
F8-Exon 13R catgtgagctagtgggcaaa
F8-Exon 14_1F ctgggaatgggagagaacct 436
F8-Exon 14_1R tttggcttcttggagatcaga
F8-Exon 14_2F tggtttgcacacagaacacc 500
F8-Exon 14_2R aagctcagaggtccaccaga
F8-Exon 14_3F cagacaatttggcagcaggt 600
F8-Exon 14_3R tttgtgcatctggtggaatg
F8-Exon 14_4F tttgaggctaaatcatatgtcaaa 399
F8-Exon 14_4R cttgattgtgtgtattattttcatgt
F8-Exon 14_5F aaagagatggtttttccaagca 560
F8-Exon 14_5R ctcggggtcaaatgtttcat
F8-Exon 14_6F tcacgcaacgtagtaagagagc 396
F8-Exon 14_6R tgactgaatttgtggcacttg
F8-Exon 14_7F aaccttggagatgactggtga 399
F8-Exon 14_7R ttccactcttcttttggtatctga
F8-Exon 14_8F ctgcaaagactccctccaag 544
F8-Exon 14_8R tgtcacaagagcagagcaaa
F8-Exon 15F ggatgtgaggcatttctaccc 299
F8-Exon 15R tgggaatacattatagtcagcaaga
F8-Exon 16F aaagacaggtatttcttttagggatg 399
F8-Exon 16R tgcacgtaggataaatatcaaaattc
F8-Exon 17F caggttggactggcataaaaa 399
F8-Exon 17R ccctggatcaagtctcatttg
F8-Exon 18F tgtgggagtggaatcctcat 367
F8-Exon 18R gtgttcccagtgcctagacc
F8-Exon 19F tctgatatttcgcataaaccaatg 280
F8-Exon 19R gcaaccattccagaaaggaa
F8-Exon 20F ttgacgttctcccattttca 243
F8-Exon 20R ttcattatctgagattctccacca
F8-Exon 21F ccacagcttagattaacctttctca 263
F8-Exon 21R tttgagcttgcaagaggaataa
F8-Exon 22F ttggtgactgcttcacttgc 371
F8-Exon 22R ccaatatctgaaatctgccaaa
F8-Exon 23F aaggaagatatgattgacagaaattg 292
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various samples and controls was evaluated and the
presence of a deletion was predicted by a minimum
of 1.5-fold decrease of peak height, corresponding to
a ratio of 0.6. Consequently, a ratio <0.6 was taken
to represent a large deletion of the corresponding
fragment.
FISH
Cell cultures A 10 mL-sample of heparin anticoagu-
lated fresh venous blood was used for the cultivation
of lymphocytes. Cell division was stopped after 72 h
by the addition of colcemid and chromosome slices
were prepared by standard procedures.
PCR amplification for probe generation Probe ampli-
fications were performed using ExpandTM Long
Template PCR System (Boehringer Mannheim,
Mannheim, Germany). The reactions were carried
out in 25 lL volume containing 10 ng BAC DNA,
20 pmol of each primer, 22 lL Long Template
buffer1 and 5 mm betaine. Primers used for PCR
assays are shown in Table 2. An initial
denaturation of 5 min at 96C was followed by
35 cycles comprising 30 s at 96C, 30 s at 62C,
4 min at 72C and a final extension step of 5 min
at 72C.
DNA labelling via nick translation and preparation of
the probes Two micrograms PCR amplified probe-
DNA was incubated in a finale volume of 100 lL
wih 10 lL 10x dNTPs (0.5 mm each of dATP, dCTP,
dGTP), 10 lL 10x NT buffer (0.5 m Tris/HCl,
50 mm MgCl2, 0.5 mg mL
)1 BSA), 1 lL 1 m mer-
captoethanol, 5 lL DNase I (1:1000), 2 lL DNA
polymerase I and 5 lL Biotin-16-dUTP 1 mm at
Table 1. Continued
Name Primer sequences (5¢ to 3¢) Length of PCR products (bp)
F8-Exon 23R aactagaacagttagtcaccctaccc
F8-Exon 24F gccctagaatatcagtggaagc 397
F8-Exon 24R caaatgcctgtgtggttgtc
F8-Exon 25F agggatttgggaatttctgg 354
F8-Exon 25R ttttgctctgaaaatttggtca
F8-Exon 26F aagcgtctgtgctttgcagt 276
F8-Exon 26R gctgaggagggagaggtgac
HGH-Exon2-3F tgccttcccaaccattccctt 434
HGH-Exon2-3R ccactcacggatttctgttgtgtttc
HGH, human growth hormone.
Table 2. Sequences and positions of primers applied for the amplification of the probes used for hybridization in fluorescent in situ
hybridization.
Name Sequence Position according to NG-005114 Size of the product
Exon1 F TTCCAAATTTTTCCTTCTCAAAGC 5¢UTR  5000
Exon1 R ATGGCAAAAACCCATCTCTAAAAA 3091–3114
Exon2 F TCCAGTAGGATACACCAACAGCAT 25716–25739 5035
Exon2 R CAGAGACTGGAGGAGGTGAGAGTT 20704–20727
Exon4 F CCATTTGAATTGGAATGAAGTTGA 32275–32298 5024
Exon4 R CCTATTCTACCAACAACCAAAGGG 27274–27297
Exon5 F CATGGATGTGGAAGTCTGATTCTC 38635–38658 5083
Exon5 R CACAGGGTCTTCCTACTTAGCCAT 33575–33598
Exon6 F TTTGTTTAGGGCCATGGCTTTGTG 33925–33948 5157
Exon6 R GTCAGAGCCCTGCCTGTCCCAAGT 39059–39082
Exon7 F GCACAGCAAAGGAAACAATCAA 50217–50238 5025
Exon7 R TTGATTATGAGGAACAGGGAAGGT 55219–55242
Exon13 F AAACATCGGCATACCCTATTGACT 72433–72456 5052
Exon13 R AAACTGATTCCACAAGGCCAGTAT 77462–77485
Exon14 F TAAGCATTCACAGGGCTTTTGGGA 90151–90174 5046
Exon14 R CTGTGGAGGTTCATTGCACAGCAT 95174–95197
Exon15 F CCACGTACATGAATTGGAAAACA 114144–114166 3450
Exon15 R TCAAAGTTTTTAATACCCTGGAAGAA 117569–117594
Exon25 F AACCAGCATAGTCCTGGGCAAACC 159765–169788 5166
Exon25 R TGTGAGTGCTCAACGAAGGGTGAC 164908–164931
Exon26 F AAGAAACAGAAGGGGTAAGAGCCT 183531–183554  5000
Exon26 R AAAGGTGAGGTGAAGTGGAGAAAG 3¢UTR
602 A. PAVLOVA et al.
 2008 The Authors
Haemophilia (2008), 14, 599–606 Journal compilation  2008 Blackwell Publishing Ltd
15C for 1.5 h. After stopping the reaction with 1 lL
10% SDS and 1 lL 0.5 m EDTA nucleotides which
were not incorporated were removed via a Sephadex
G 50 colum. After saturating repetitive sequences
with human Cot-DNA and salmon testis DNA the
labelled DNA was precipitated and resuspended in
40 lL of Hybridization-Mix (50% formamide, 2x
SSC, 10% dextran sulphate).
Hybridization and detection of the signals Ten micro-
litres of the labelled probe were mixed with 1 lL of a
2-kb BamHI fragment of the alpha-satellite DNA
from Xc which served as an internal control and
hybridized to metaphase chromosomes of the pro-
bands for 48 h at 37C. The labelled chromosomes
were detected by binding of FITC labelled avidin to
bound biotin-16-dUTP.
Results
Detection of large deletions in the index patients
Absence of intron 22 and intron 1 inversionmutations
were confirmed for all index patients. Thirty-three
fragments representing all 26 exons and exon/intron
boundaries were amplified from each patient for
further mutation screening analysis (Table 1). Repet-
itive failures in PCR amplification of one or more
neighboured exons indicated the presence of a large
deletion of the corresponding exons. In 14 patients,
single exon deletions were identified including exons
1, 6, 13, 14, 21, 22 and 26.Multi-exon deletions were
detected for each of five patients that comprised exons
1–6, exons 15–18, exons 15–22, exons 23–24or exons
1–25.
Detection of large deletions in female relatives
Based on the localization and extension of the large
deletion in the index patient, a set of primers that
allowed amplifying the deleted and flanking exons
were used (Table 1).
For determination of the deletion in exon 1
(families 1–4), exons 1–5 and 8 were amplified in a
multiplex reaction. In family 3, the mother of the
index patient showed a peak height ratio of 0.3 and
was identified as a carrier, while the sister showed a
ratio of 1.0, indicating no deletion. In families 1, 2
and 4, three female relatives were identified as
carriers with ratios for exon 1 in the range of 0.4–
0.5 (Table 3, Fig. 1a).
The deletion of exon 6 was examined in three
females belonging to families 5 and 6 by amplifica-
tion of exons 3, 5, 6 and 9. The two mothers were
found to be carriers for the deletion (ratios of 0.5–
0.6). The sister of the proband of family 5 was
identified as a non-carrier (ratio of 0.9) (Fig. 1b).
The deletion of exon 13 in family 7 was not
present in the mother of the index patient. Repetitive
analysis confirmed a normal peak height ratio of
0.95–1.00.
Three index patients exhibited a deletion of exon
14 (families 8–10). In two of the families, the
deletion spans all of exon 14 (family 9 and 10),
while in family 8, only the second half of exon 14
was deleted (lack of PCR products from 14-5 to
14-8). Both the mother and the sister in family 8
exhibited the deletion of fragments 14-5 (ratio 0.4)
and were identified as carriers. In families 9 and 10,
both mothers carried a deletion corresponding to
fragments 14-1 and 14-8 indicating a deletion of the
entire exon 14. In the amplified flanking exons 13
and 15, the peak height ratios were 1.0.
Deletions of exons 21, 22 and 26 were identified in
families 11, 12, 13 and 14. The sister of the index
patient in family 11 did not carry the deletion of
exon 21 (ratio 0.9). A deletion was assigned to the
Table 3. Localization of deletions in index patients and the results
in their female relatives analysed by multiplex PCR-liquid chro-
matogphy and fluorescent in situ hybridization.
Family
number
Deletion
in index
patient
Female Ratio for
deleted
exon(s) FISH
Female
relative
Multiplex
PCR-LC
1 Ex 1 Sister Carrier 0.4 n.d.
2 Ex 1 Mother Carrier 0.5 n.d.
3 Ex 1 Mother Carrier 0.3 n.d.
Sister Normal 1.0 n.d.
4 Ex 1 Sister Carrier 0.4 n.d.
5 Ex 6 Mother Carrier 0.5 Carrier
Sister Normal 0.9 n.d.
6 Ex 6 Mother Carrier 0.6 n.d.
7 Ex13 Mother Normal 1.0 n.d.
8 Ex 14.5–
14.8
Mother Carrier 0.4–0.5 n.d.
Sister Carrier 0.4.0.6 n.d.
9 Ex 14 Mother Carrier 0.4–0.6 n.d.
10 Ex 14 Mother Carrier 0.4–0.6 Carrier
11 Ex 21 Sister Normal 0.9 n.d.
12 Ex 22 Mother Carrier 0.4 n.d.
13 Ex 26 Mother Carrier 0.5 n.d.
14 Ex 26 Mother Carrier 0.6 n.d.
15 Ex 1–6 Mother Carrier 0.3–0.5 n.d.
16 Ex 15–18 Mother Carrier 0.3–0.4 n.d.
17 Ex 15–22 Mother Carrier 0.3–0.5 n.d.
18 Ex 23–24 Aunt Normal 0.9–1.0 n.d.
19 Ex 1–25 Grand
mother
Normal 0.8–1.0 n.d.
Mother Carrier 0.3–0.6 Carrier
Sister Normal 0.8–1.0 n.d.
n.d., not determined.
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patients mothers in family 12 for exon 22 (ratio 0.4)
and in families 13 and 14 for exon 26 (ratio 0.5–0.6)
(Table 3).
Families 15–19 exhibited multi-exon deletions
ranging from 4 to 25 exons. A deletion of exons
1–6 was found in the index patient of family 15. The
mother was proven to be a carrier with peak height
ratios in the range of 0.3–0.5. Exon 6 was excluded
from analysis because of its similar size to exon 1.
Exon 7 was analysed as an unaffected flanking
control exon and exhibited a ratio of 1.0.
In families 16 and 17, both mothers were found to
carry a deletion, that in family 16 extending from
exon 15 to 18 (ratio 0.3–0.4) and in family 17 from
exon 15 to 22. Flanking exons 14-8 and 21 showed
no deletion (Table 3).
In family 18, deletion of exons 23 and 24 was
not found in the probands aunt (ratio 0.9–1.0). In
family 19, we studied three females. The deletion
in the index patient covered nearly the whole F8
gene (from exon 1 to 25). Subsets of the first exons
(1–5 and 8) and of the last exons (21–24) were
examined and the deletion was found to be present
in the mother but not in either grandmother or
sister (Fig. 1c).
FISH
A fluorescent in situ hybridization (FISH) analysis
was performed to confirm the large deletions in
females in three families (families 5, 10 and 19).
Probes were designed to be located within or flanking
the deletions and were hybridized to the X-chromo-
somes of the female relatives of the index patients.
Female carriers of a deletion exhibit centromeric
signals on both X-chromosomes, while the F8 signal
is only found on the normal X-chromosome. In
contrast, non-carrier females exhibit two F8 signals
and two centromeric signals (Fig. 2). Hybridization
with a probe for exon 6 of metaphase chromosomes
of the family 5 patients mother resulted in a signal
only on one X-chromosome (Fig. 2a1), while hybrid-
ization with a probe for exon 5 resulted in signals on
both X-chromosomes (Fig. 2a2) indicating that she is
a carrier of the deletion of exon 6. The probands
mother from family 10 exhibited a signal on only one
(a)
(b)
carrier
carrier
HGH
HGH HGH
HGHHGH
Ex 5 Ex 3
Ex 5 Ex 3 Ex 1 Ex 2 Ex 4 Ex 8 Ex 21 Ex 23Ex 22 Ex 24
Ex 9 Ex 6
ratio 1.0
ratio
Ex 5 Ex 3 Ex 1 Ex 2 Ex 4 Ex 8 Ex 21 Ex 23 Ex 22 Ex 24
ratio
0.3
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0.4 0.4 0.4 0.4 0.40.3 0.3 0.30.5
1.0 1.0 0.6
non carrier
non carrier
HGH
Ex 5 Ex 3 Ex 9 Ex 6
1.0 1.0 1.0 1.0
Fig. 1. Chromatograms of representative
families with various deletions. The black
line marks the control and the red line
indicates the test sample. The deleted
exon(s) are pointed out by arrows. The
ratio is given under each fragment.
(a) Family 3: heterozygous deletion of exon
1 in a carrier (left side); non-deleted exon 1
in a non-carrier (right side). (b) Family 5:
heterozygous deletion of exon 6 in a carrier
(left side); non-deleted exon 6 in a non-
carrier (right side). (c) Family 17: hetero-
zygous deletion of the whole F8 gene in a
carrier (upper part) and absence of the
deletion in a non-carrier (lower part).
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X-chromosome when probed for exon 14 hybridiza-
tion (Fig. 2b1). Hybridization with the flanking exon
13 resulted in signals on both X-chromosomes
(Fig. 2b2). In family 19, the deletion was confirmed
in the patients mother as verified by only one signal
upon hybridization to a probe of exon 25 and by two
signals when the flanking exon 26 was probed.
Discussion
In the present study we describe the successful
diagnosis of 16 heterozygous large deletions of the
F8 gene in 24 female relatives of 19 severe HA
patients by a multiplex PCR-LC method. As the F8
gene encompasses 26 exons and large deletions are
not clustered in any specific region of the gene,
carrier detection in females represents a challenge.
This situation is even more complicated when the
index patient is not available.
We employed a rapid multiplex PCR-LC tech-
nique that had been previously established in our
lab for the detection of heterozygous large dele-
tions of the antithrombin gene [12]. By quantifica-
tion of potentially deleted exons, accurate
classifications of carriers and non-carriers of het-
erozygous large deletions in the F8 gene is
achieved. This technique also provides reliable
results when no index patient is available. Unlike
other available techniques including capillary gel
electrophoresis, multiplex amplifiable probe hybrid-
ization and multiplex ligation-dependent probe
amplification, the multiplex PCR-LC method
enables carrier detection without the use of radio-
isotopes, fluorescence-labelled or gel-based reagents
[13,14]. Compared with classical Southern blotting,
a significant reduction in handling time and
improved detection of all deletions, including the
determination of their size, is achieved.
All patients mothers were carriers of the hetero-
zygous large deletions, except for family 7 where the
absence of a large deletion in the patients mother
indicated a de novo mutation either in the germ cells
or a somatic mosaicism. Large deletions within the
F8 gene are known to originate predominantly from
female germ cells because homologous recombina-
tion of both X-chromosomes during meiosis can
enhance appearance of large deletions [15–18].
Therefore, it is of particular importance to determine
the carrier status of the mothers of HA patients
presenting large deletion genotypes. Among the
investigated sisters of patients in the present study,
three were identified as carriers and four as non-
carriers. The aunt in family 18 and the grandmother
in family 19 were also found to be non-carriers
(Table 3). In three families, the deletion was addi-
tionally confirmed by FISH-technique. Although
FISH allows direct visual analysis, it is rather
laborious, especially when a deletion is not con-
firmed a priori and when several regions of the F8
gene must be analysed. However, FISH does provide
a suitable technique for the reliable identification of
heterozygous large deletions in females [19].
Accurate carrier detection of females with large
deletions is important for purposes of genetic coun-
selling as large deletions in male descendents always
lead to the severe clinical phenotype of haemophilia,
often complicated by inhibitor development. Addi-
tionally, the risk of inhibitor formation for such
patients correlates with the size of the deletion. For
multi-domain deletions, the patients exhibit an
(a1)
(b1)
(c1)
(a2)
(b2)
(c2)
Fig. 2. Fluorescent in situ hybridization
results of families 5, 10 and 19. Left-hand
side: hybridization with a probe that binds
to the deleted exon/region (a1 – exon 6;
b1 – exon 14; c1 – exon 25) results in a
signal on only one of the two X-chromo-
somes. Right-hand side: hybridization with
a probe binding to the deletions flanking
exons/regions (a2 – exon 5; b2 – exon 13;
c2 – exon 26) resulted in signals on both
X-chromosomes.
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elevated risk (88%) for inhibitor development, while
this risk is decreased (41%) for single domain
deletions [20–22].
In conclusion, the multiplex PCR-LC technique
described here can reliably identify HA female
carriers of heterozygous large deletions, an attractive
alternative to previously reported methods. The
method is rapid, simple and robust and is, therefore,
well suited for routine diagnostics. It can also be
successfully applied to screening and identification of
asymptomatic carrier females even when the index
patient has not been genetically analysed and, thus,
represents a new, powerful tool for genetic counsel-
ling for HA families.
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